Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.4%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 4.4% to $10.17 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.

This was the stock's fourth consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 50.5% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 2.2% to $5.00, Fortress Biotech Inc. fell 3.6% to $2.67, and Viking Therapeutics Inc. rose 2.88% to $34.26.

Trading volume totaled 352,885, compared to the 50-day average of 447,114.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 07, 2026 16:35 ET (20:35 GMT)